NO127735B - - Google Patents
Download PDFInfo
- Publication number
- NO127735B NO127735B NO03070/69A NO307069A NO127735B NO 127735 B NO127735 B NO 127735B NO 03070/69 A NO03070/69 A NO 03070/69A NO 307069 A NO307069 A NO 307069A NO 127735 B NO127735 B NO 127735B
- Authority
- NO
- Norway
- Prior art keywords
- blood
- pressure
- temperature
- storage
- compression
- Prior art date
Links
- 210000004369 blood Anatomy 0.000 claims description 83
- 239000008280 blood Substances 0.000 claims description 83
- 238000007906 compression Methods 0.000 claims description 40
- 230000006835 compression Effects 0.000 claims description 39
- 238000007710 freezing Methods 0.000 claims description 32
- 230000008014 freezing Effects 0.000 claims description 31
- 238000000034 method Methods 0.000 claims description 20
- 230000009931 harmful effect Effects 0.000 claims description 5
- 238000002194 freeze distillation Methods 0.000 claims description 2
- 230000003247 decreasing effect Effects 0.000 claims 1
- 210000003743 erythrocyte Anatomy 0.000 description 27
- 210000004027 cell Anatomy 0.000 description 20
- 239000012528 membrane Substances 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical group [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 8
- 239000007788 liquid Substances 0.000 description 7
- 230000003204 osmotic effect Effects 0.000 description 7
- 239000003146 anticoagulant agent Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 230000033001 locomotion Effects 0.000 description 6
- 230000037323 metabolic rate Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 206010018910 Haemolysis Diseases 0.000 description 5
- 229940127219 anticoagulant drug Drugs 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000008602 contraction Effects 0.000 description 5
- 230000008588 hemolysis Effects 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 229910000831 Steel Inorganic materials 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- 238000006073 displacement reaction Methods 0.000 description 4
- 210000003617 erythrocyte membrane Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 229910052759 nickel Inorganic materials 0.000 description 4
- 210000002381 plasma Anatomy 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- 239000010959 steel Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 102000001554 Hemoglobins Human genes 0.000 description 3
- 108010054147 Hemoglobins Proteins 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 230000035899 viability Effects 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 230000010339 dilation Effects 0.000 description 2
- 238000009713 electroplating Methods 0.000 description 2
- 210000003722 extracellular fluid Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 238000005534 hematocrit Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 210000002977 intracellular fluid Anatomy 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 2
- 229940038773 trisodium citrate Drugs 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- IJRKANNOPXMZSG-SSPAHAAFSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC(=O)CC(O)(C(O)=O)CC(O)=O IJRKANNOPXMZSG-SSPAHAAFSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241001552669 Adonis annua Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000004555 blood preservation Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003040 circulating cell Anatomy 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000007772 electrode material Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 108091005899 fibrous proteins Proteins 0.000 description 1
- 102000034240 fibrous proteins Human genes 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000002433 hydrophilic molecules Chemical class 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229920002529 medical grade silicone Polymers 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/16—Physical preservation processes
- A01N1/165—Pressure processes, e.g. following predefined pressure changes over time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A61M1/0272—Apparatus for treatment of blood or blood constituents prior to or for conservation, e.g. freezing, drying or centrifuging
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Dentistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75719568A | 1968-08-08 | 1968-08-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO127735B true NO127735B (it) | 1973-08-13 |
Family
ID=25046791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO03070/69A NO127735B (it) | 1968-08-08 | 1969-07-24 |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US3579999A (it) |
| AT (1) | AT303260B (it) |
| BE (1) | BE736499A (it) |
| BR (1) | BR6910970D0 (it) |
| CA (1) | CA934299A (it) |
| CH (1) | CH540694A (it) |
| DE (1) | DE1938005A1 (it) |
| DK (1) | DK125738B (it) |
| ES (1) | ES369461A1 (it) |
| FR (1) | FR2070057B1 (it) |
| GB (1) | GB1270996A (it) |
| IL (1) | IL32630A (it) |
| IT (1) | IT1051232B (it) |
| LU (1) | LU59156A1 (it) |
| NL (1) | NL6910821A (it) |
| NO (1) | NO127735B (it) |
| OA (1) | OA03106A (it) |
| RO (1) | RO58790A (it) |
| ZA (1) | ZA694993B (it) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2349532A1 (de) * | 1972-10-03 | 1974-04-25 | Nippon Denso Co | Zuendzeitpunkt-steuereinrichtung fuer motoren |
| US3979910A (en) * | 1973-04-16 | 1976-09-14 | Canada Wire And Cable Limited | Closed circuit hydraulic control system |
| US4082509A (en) * | 1976-08-05 | 1978-04-04 | Dow Corning Corporation | Method of storing blood and a blood storage bag therefor |
| GB2203022B (en) * | 1987-03-23 | 1991-11-20 | Imp Tobacco Co Ltd | Smoking material and process for making the same |
| US6270723B1 (en) | 1998-06-15 | 2001-08-07 | Bbi Bioseq, Inc. | Rapid cryobaric sterilization and vaccine preparation |
| US6696019B2 (en) * | 1998-06-15 | 2004-02-24 | Bbi Bioseq, Inc. | Rapid cryobaric sterilization and vaccine preparation |
| US6413713B1 (en) * | 1998-10-30 | 2002-07-02 | Hyperbaric Systems | Method for preserving blood platelets |
| WO2000053008A1 (en) * | 1999-03-11 | 2000-09-14 | Hyperbaric Systems | Compositions and methods for preserving platelets |
| AU2002246493A1 (en) * | 2000-08-10 | 2002-07-30 | Boston Biomedica, Inc. | Pressure cycling inactivation of pathogens in biological materials used for therapeutics or vaccines |
| US20030158507A1 (en) * | 2001-06-26 | 2003-08-21 | Vladimir Serebrennikov | Preservation of blood platelets at cold temperatures |
| US7029839B2 (en) * | 2003-04-23 | 2006-04-18 | Human Biosystems | Methods and solutions for storing donor organs |
| DE102011115467A1 (de) * | 2011-10-10 | 2013-04-11 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Vorrichtung und Verfahren zur Druck-Kryokonservierung einer biologischen Probe |
| GB201207543D0 (en) * | 2012-05-01 | 2012-06-13 | Haemair Ltd | Treatment of transfusion blood |
| EP2674033A1 (en) * | 2012-06-11 | 2013-12-18 | Deutsches Institut für Lebensmitteltechnik e.V. | Process for producing a composition containing active follistatin |
| EP3645403B1 (en) * | 2017-08-11 | 2025-03-26 | The Regents of the University of California | Process for temperature and pressure controlled cryopreservation |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1319136A (en) * | 1919-10-21 | Anthony henry bieker | ||
| US653956A (en) * | 1899-05-15 | 1900-07-17 | Bergl Australia Ltd | Process of making foods from blood. |
| US858504A (en) * | 1906-10-25 | 1907-07-02 | Frederick M Ekert | High-resisting body. |
| US1127144A (en) * | 1911-06-09 | 1915-02-02 | Samuel S Williamson | Non-refillable bottle. |
| US2327041A (en) * | 1942-01-12 | 1943-08-17 | American Dairy Cattle Club | Heat exchange material |
| US2587728A (en) * | 1944-07-19 | 1952-03-04 | Grove Regulator Company | Loading means for pressure regulators |
| US2564232A (en) * | 1946-04-03 | 1951-08-14 | Steel Products Eng Co | Filler cap assembly |
| US2662520A (en) * | 1951-02-06 | 1953-12-15 | Little Inc A | Preservation and storage of biological materials |
| US2645242A (en) * | 1952-04-11 | 1953-07-14 | Hydraulic Res & Mfg Co Inc | Valve |
| FR1089163A (fr) * | 1953-12-09 | 1955-03-15 | Little Inc A | Perfectionnements relatifs à la conservation et au stockage de matières biologiques |
| US2916174A (en) * | 1955-07-21 | 1959-12-08 | Spray Products Corp | Dual seal closure gasket |
| US2968320A (en) * | 1955-08-10 | 1961-01-17 | Gratzmuller Jean Louis | Hydropneumatic accumulators |
| FR1181294A (fr) * | 1957-08-19 | 1959-06-12 | Renault | Perfectionnements aux détendeurs |
| US3136340A (en) * | 1960-06-17 | 1964-06-09 | Mc Graw Edison Co | Accumulator for hydraulic systems |
| US3295545A (en) * | 1963-12-13 | 1967-01-03 | Papell Solomon Stephen | Liquid storage tank venting device for zero gravity environment |
| US3329297A (en) * | 1964-07-27 | 1967-07-04 | Aerojet General Co | Submersible polylithic vessel |
| US3321347A (en) * | 1964-08-10 | 1967-05-23 | Douglas Aircraft Co Inc | Method of making a metallic-lined pressure vessel |
| US3406531A (en) * | 1964-08-25 | 1968-10-22 | Emil S. Swenson | Apparatus for maintaining organs in a completely viable state |
| US3462041A (en) * | 1968-09-13 | 1969-08-19 | Gen Dynamics Corp | High pressure sealing structure |
| US3615036A (en) * | 1968-10-17 | 1971-10-26 | Int Harvester Co | Locking filler cap |
-
1968
- 1968-08-08 US US757195A patent/US3579999A/en not_active Expired - Lifetime
-
1969
- 1969-07-12 ES ES369461A patent/ES369461A1/es not_active Expired
- 1969-07-14 NL NL6910821A patent/NL6910821A/xx unknown
- 1969-07-15 ZA ZA694993A patent/ZA694993B/xx unknown
- 1969-07-15 DK DK382769AA patent/DK125738B/da unknown
- 1969-07-15 IL IL32630A patent/IL32630A/en unknown
- 1969-07-16 CA CA057201A patent/CA934299A/en not_active Expired
- 1969-07-23 LU LU59156A patent/LU59156A1/xx unknown
- 1969-07-24 BR BR210970/69A patent/BR6910970D0/pt unknown
- 1969-07-24 FR FR696925209A patent/FR2070057B1/fr not_active Expired
- 1969-07-24 AT AT714069A patent/AT303260B/de not_active IP Right Cessation
- 1969-07-24 IT IT4708/69A patent/IT1051232B/it active
- 1969-07-24 NO NO03070/69A patent/NO127735B/no unknown
- 1969-07-24 BE BE736499D patent/BE736499A/xx unknown
- 1969-07-25 GB GB37587/69A patent/GB1270996A/en not_active Expired
- 1969-07-25 OA OA53687A patent/OA03106A/xx unknown
- 1969-07-25 CH CH1141469A patent/CH540694A/de not_active IP Right Cessation
- 1969-07-25 DE DE19691938005 patent/DE1938005A1/de active Pending
- 1969-08-08 RO RO60757A patent/RO58790A/ro unknown
-
1971
- 1971-04-06 US US00131803A patent/US3841515A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| GB1270996A (en) | 1972-04-19 |
| CA934299A (en) | 1973-09-25 |
| NL6910821A (it) | 1970-02-10 |
| DK125738B (da) | 1973-04-30 |
| IT1051232B (it) | 1981-04-21 |
| US3841515A (en) | 1974-10-15 |
| IL32630A0 (en) | 1969-09-25 |
| IL32630A (en) | 1973-08-29 |
| FR2070057A1 (it) | 1971-09-10 |
| US3579999A (en) | 1971-05-25 |
| ES369461A1 (es) | 1971-06-16 |
| LU59156A1 (it) | 1971-07-14 |
| RO58790A (it) | 1976-01-15 |
| BE736499A (it) | 1970-01-26 |
| CH540694A (de) | 1973-08-31 |
| BR6910970D0 (pt) | 1973-04-19 |
| FR2070057B1 (it) | 1973-07-13 |
| OA03106A (fr) | 1970-12-15 |
| AT303260B (de) | 1972-11-27 |
| ZA694993B (en) | 1971-02-24 |
| DE1938005A1 (de) | 1970-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO127735B (it) | ||
| EP1124413B1 (en) | Method and apparatus for preserving biological materials | |
| McCarey et al. | Improved corneal storage | |
| US4688387A (en) | Method for preservation and storage of viable biological materials at cryogenic temperatures | |
| RU2489855C2 (ru) | Устройство для консервации печеночного трансплантата в условиях нормотермии | |
| CN112638157B (zh) | 一种防止样品和细胞外冰直接接触的有效低温保存装置 | |
| Crawford et al. | Sodium transport by the chorioallantoic membrane of the pig | |
| CN109964921A (zh) | 冰点以下温度保存生物物质的多相定容装置、系统和方法 | |
| EP1161143B1 (en) | Compositions and methods for preserving platelets | |
| CN214229612U (zh) | 一种低温保存装置 | |
| US3677022A (en) | Method for extending the useful storage period of biological substances such as blood | |
| JP7560898B2 (ja) | 細胞の凍結保存装置 | |
| Karow Jr et al. | Survival of dog kidneys subjected to high pressures: necrosis of kidneys after freezing | |
| JP3761758B2 (ja) | 殺菌方法および殺菌装置 | |
| US12096766B2 (en) | Process for cooling a biological material and the storage thereof | |
| RU62810U1 (ru) | Барокамера для консервации донорских тканей | |
| CN117902184B (zh) | 一种用于大体积生物样本的自增压过冷储运装置 | |
| Ugraitskaya et al. | The Effect of Helium on Cryopreservation of HeLa and L929 Cells | |
| CN119054683B (zh) | 一种用于肾脏类器官的冻存液、制备方法及使用方法 | |
| RU2748496C1 (ru) | Способ сохранения органов и тканей в составе целостного организма в жидкости при температурах ниже 0оС под давлением в среде инертного газа | |
| RU2847325C1 (ru) | Способ поддержания жизнеспособности трансплантируемого органа в консервирующей газовой смеси и набор для его реализации | |
| Doughty | Sided effects of bicarbonate on rabbit corneal endothelium in vitro | |
| Pegg | Cryobiology-a review | |
| DE19826350A1 (de) | Verfahren und Vorrichtung zum Konservieren von zellulären Blutkomponenten | |
| CN117546833A (zh) | 一种类器官冻存液的制备方法 |